Drainage Versus Sealant in Double Blinded Monocentric Open Incisional Hernia Repair
DREAM
1 other identifier
interventional
57
1 country
2
Brief Summary
Mesh repair for open incisional hernia repair with fibrin sealant or with drainage
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2010
Longer than P75 for phase_4
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2008
CompletedFirst Posted
Study publicly available on registry
October 17, 2008
CompletedStudy Start
First participant enrolled
January 27, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 14, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 24, 2018
CompletedJune 26, 2018
June 1, 2018
4.7 years
October 16, 2008
June 22, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Hospital stay
At time of discharge
Secondary Outcomes (5)
Postoperative drainage volume
Day 0,1, 2, 3 ? and at day of removal
Perioperative morbidity rate
At time of discharge
Pain measured using VAS
Daily till discharge and after 3 weeks post-surgery
Quality of life by SF-36 questionnaire
Preoperatively, at time of discharge, 2 weeks after discharge, 6 weeks after discharge and 1 year post surgery
Recurrence
At one year
Study Arms (2)
1
EXPERIMENTALStudy group (Tisseel®)
2
OTHERControl group
Interventions
Eligibility Criteria
You may qualify if:
- All patients with a large incisional hernia \>5cm diameter that needs elective repair with mesh augmentation
You may not qualify if:
- no written informed consent
- 'hostile' abdomen
- emergency surgery (incarcerated hernia)
- parastomal hernia
- incisional hernia outside the midline
- recurrent incisional hernia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Ghentlead
- Baxter Healthcare Corporationcollaborator
Study Sites (2)
University Hospital Ghent
Ghent, 9000, Belgium
UZ gasthuisberg Leuven
Leuven, Belgium
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frederik Berrevoet, MD
University Hospital, Ghent
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2008
First Posted
October 17, 2008
Study Start
January 27, 2010
Primary Completion
October 14, 2014
Study Completion
May 24, 2018
Last Updated
June 26, 2018
Record last verified: 2018-06